24.01.2024 21:31:05
|
JNJ Agrees To $700 Mln Settlement To Resolve Talc Consumer Protection Claims
(RTTNews) - Johnson & Johnson (JNJ) has agreed to a tentative settlement of $700 million to address certain consumer protection claims and a portion of the talc litigation it is currently facing.
Despite two unsuccessful attempts to handle the cases through bankruptcy, J&J plans to pay $700 million to 42 states and the District of Columbia to address claims regarding its talcum-based products, including Johnson's Baby Powder.
Mississippi and New Mexico have not agreed to the settlement, as they are seeking larger settlements through separate lawsuits filed against J&J. The agreement was first reported by Bloomberg two weeks ago, with the company confirming the news to the Wall Street Journal on Tuesday.
The company is still dealing with over 50,000 lawsuits related to talc, primarily from women with ovarian cancer, and fewer cases involving people with mesothelioma. According to the Lawsuit Informational Center, the company has offered $6.9 billion to resolve ovarian cancer claims. J&J is working to address the ovarian cancer and mesothelioma claims separately.
J&J is also facing legal action from shareholders who allege that the company concealed knowledge of its talc products containing cancer-causing asbestos between 2013 and 2018. Despite discontinuing the sale of talc-based baby powder in North America in 2020 and worldwide in 2023, J&J continues to assert the safety of its talc-based products.
The company stopped selling talc-based baby powder in favor of cornstarch-based products, citing an increase in lawsuits and concerns about the safety of the talc product.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
12.03.25 |
Börse New York: Dow Jones in der Gewinnzone (finanzen.at) | |
12.03.25 |
Angespannte Stimmung in New York: Dow Jones sackt mittags ab (finanzen.at) | |
12.03.25 |
Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel Gewinn hätte ein Johnson Johnson-Investment von vor einem Jahr eingefahren (finanzen.at) | |
05.03.25 |
Zuversicht in New York: Dow Jones letztendlich mit Kursplus (finanzen.at) | |
05.03.25 |
Zuversicht in New York: Dow Jones am Nachmittag freundlich (finanzen.at) | |
05.03.25 |
Dow Jones 30 Industrial-Titel Johnson Johnson-Aktie: So viel Gewinn hätte ein Investment in Johnson Johnson von vor 10 Jahren eingebracht (finanzen.at) | |
04.03.25 |
Minuszeichen in New York: Dow Jones zum Start des Dienstagshandels im Minus (finanzen.at) | |
03.03.25 |
Verluste in New York: Dow Jones fällt zum Ende des Montagshandels zurück (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 149,44 | -0,36% |
|